Abstract
The approach of this proposal is to use drug discovery leads from DNDi as starting points to deliver clinical candidates meeting the target product profiles (TPPs) for Chagas disease and visceral leishmaniasis (VL). The goal of this project is to deliver an optimised lead compound ready for preclinical and subsequently clinical development for the treatment of Chagas disease and/or viscer…